Related Experiment Videos
Clinical effects of fluvoxamine on panic symptomatology
H Pols1, J Zandergen, C de Loof
1Department of Clinical Psychiatry, State University of Limburg, Maastricht, The Netherlands.
Acta Psychiatrica Belgica
|May 1, 1993
Abstract:
In a double-blind randomized placebo-controlled cross-over design trial, the effects of a 4 week fluvoxamine versus a 4 week placebo treatment regimen on panic symptomatology were studied. Fluvoxamine seems to have specific antipanic properties, as a significant decrease in the number of panic attacks was observed. Other components of the disorder, like free-floating anxiety and avoidance behavior were not influenced during the short 4 week treatment period.